Clinical Trial to Investigate Whether Hypertension Drug Ameliorates COVID-19 Severity

UC San Diego scientists have launched a clinical trial to investigate whether a drug approved for treating high blood pressure might also reduce the severity of COVID-19 infections, lowering rates for intensive care unit admissions, the use of mechanical ventilators and all-cause mortality.

Read more